Similar articles

• Proceedings: Review of the cardiovascular pharmacology of perhexiline.

  Hudak WJ, Lewis RE, Lucas RW, Kuhn WL. Hudak WJ, et al. Postgrad Med J. 1973 Apr;49:Suppl 3:16-25. Postgrad Med J. 1973. PMID: 4202743 Review. No abstract available.
• Soft drug derivatives related to perhexiline. Part II: In vivo studies.

  Decker N, Grima M, Velly J, Marciniak G, Leclerc G, Schwartz J. Decker N, et al. Arzneimittelforschung. 1988 Aug;38(8):1110-4. Arzneimittelforschung. 1988. PMID: 3196404
• [Experimental anti-arrhythmic action of perhexiline].

  Sánchez-Pérez S, Pastelín G, Valenzuela F, Méndez R. Sánchez-Pérez S, et al. Arch Inst Cardiol Mex. 1976 Nov-Dec;46(6):696-706. Arch Inst Cardiol Mex. 1976. PMID: 799493 Clinical Trial. Spanish.
• [Pexide, a new coronary drug].

  Garten J, Werhrschütz E. Garten J, et al. Ther Ggw. 1975 Jun;114(6):957. Ther Ggw. 1975. PMID: 1096350 Clinical Trial. German. No abstract available.
• Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.

  Chong CR, Sallustio B, Horowitz JD. Chong CR, et al. Cardiovasc Drugs Ther. 2016 Aug;30(4):399-405. doi: 10.1007/s10557-016-6664-3. Cardiovasc Drugs Ther. 2016. PMID: 27106834 Review.